Keywords: ligand, revenues, leap, product, sales, double, pharmaceuticals
Ligand revenues leap 59%, as product sales double
Article | 18 March 2002
Ligand Pharmaceuticals of the USA recorded total revenues of $76.3million for 2001, an increase of 59%, with net product sales growing 99% to $45.6 ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US Supreme Court says patent settlement can "sometimes" be illegal
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
- Daiichi Sankyo files for Japanese approval of Prasugrel
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
